BeStock  
Markets › Compare › TNDM vs LBRX

TNDM vs LBRX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
TNDM · Tandem Diabetes Care$15.84 ▼ 1.98%
LBRX · LB Pharmaceuticals$34.16 ▼ 0.29%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

73137201266330Oct 9, '25Apr 9, '26Oct 7, '26
  • TNDM +6.9%
  • LBRX +118.4%

Head to head

MetricTNDMLBRX
Price$15.84$34.16
Change today▼ 1.98%▼ 0.29%
Market cap$1.10B$1.10B
Return, 3 months+3.1%+1.2%
Return, year to date-27.9%+53.5%
Return, 1 year+3.3%+127.1%
P/E (TTM)-17.6-11.4
P/B8.53.3
P/E percentile vs own 5y30th84th
Dividend yield––
Revenue growth (YoY, latest qtr)+5.8%–
Net profit growth (YoY)+59.6%-959.4%
Gross margin56.0%–
Operating margin-4.4%–
Net margin-6.1%–
Return on equity-48.0%-75.0%
Analyst target vs. price+77.9%+89.9%
Analyst buy share58%100%
RSI (14)3626
30-day volatility52.9%44.4%
Max drawdown, 1 year-54.6%-31.0%
Trend readLeaning bearishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • TNDM is the largest of the group by market value.
  • LBRX has returned the most over the past year.
  • TNDM carries the lowest trailing P/E.
  • LBRX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top